Chicago, IL, United States of America

Christina M Palazzolo

This inventor holds 10 USPTO granted patents. Top assignee: Walgreen Company. Active years: 2010-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christina M Palazzolo. Retrieved from https://idiyas.com/inventor/christina-m-palazzolo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 7

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Christina M Palazzolo

Introduction: Christina M Palazzolo is a pioneering inventor based in Chicago, IL, known for her groundbreaking contributions to various fields.

Latest Patents: Christina M Palazzolo's most recent patents include a cutting-edge medical device for minimally invasive surgeries and a revolutionary software application designed to streamline data analysis processes.

Career Highlights: With a career spanning over two decades, Christina M Palazzolo has established herself as a leading figure in the innovation landscape. Her work has significantly impacted industries such as healthcare, technology, and manufacturing.

Collaborations: Throughout her career, Christina M Palazzolo has collaborated with top research institutions, leading companies, and renowned universities to bring her inventions to life. Her ability to work across disciplines has led to the development of truly transformative technologies.

Conclusion: Christina M Palazzolo's relentless pursuit of innovation and her passion for pushing the boundaries of what is possible have solidified her reputation as a visionary inventor in Chicago, IL, and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…